There Were 5 Precision Medicine Products in 2008. How Many There Are Now May Surprise You

There Were 5 Precision Medicine Products in 2008.  How Many There Are Now May Surprise You

Few markets grow 26 times their size. But that may have happened with the precision medicine market. The field of personalized medicine continues to make progress, delivering significant benefits to patients but also facing challenges. Kalorama's general sentiments about this market are confirmed in some sense by the March 2017 publication of a Personalized Medicine Coalition's report.


Recent Autism Test Studies Add to Promising, Yet Inconclusive Research into Psychiatric Diagnostics

Recent Autism Test Studies Add to Promising, Yet Inconclusive Research into Psychiatric Diagnostics

In two recent studies, in vitro diagnostic (IVD) assays have been investigated that incorporate biomarkers for environmental factors and dysfunctional cellular pathways associated with autism spectrum disorders (ASDs). The accuracy of these oftentimes complex lab tests for ASD has improved with extensive genomic research into the disorder among large groups of ASD-affected families and between ASD and neurotypical siblings. While the clinical utility of a diagnostic lab test for ASD or ASD predisposition would be unquestionably high (particularly in young children and infants), additional research and assay validation across ASD populations is necessary to secure widespread clinical acceptance and payer coverage.


Introducing the New Kalorama Information Knowledge Center

Introducing the New Kalorama Information Knowledge Center

Kalorama Information has introduced an updated version of our popular Knowledge Center, a one-stop platform that unifies Kalorama's authoritative content and revolutionizes the way clients access and use market research.


Moderate Growth in the $26 Billion-Dollar Respiratory Devices Market

Moderate Growth in the $26 Billion-Dollar Respiratory Devices Market

Faster growth than most medical devices and expected demand due to a world aging population makes respiratory devices a category where growth can be expected.


Urgent Care Centers Thrive As Potential Solution to Physician Crunch

Urgent Care Centers Thrive As Potential Solution to Physician Crunch

The Urgent Care Industry is prospering for a good reason. There is more demand for doctors than there is supply. But how many urgent care centers are there in the U.S.? And what is the growth trend for urgent cares. We look at these questions and also talk about the challenges facing the urgent care business model.


Pharma, Diagnostics and Biotech Caught in Legislative Crossfire with Release of White House Budget Blueprint

Pharma, Diagnostics and Biotech Caught in Legislative Crossfire with Release of White House Budget Blueprint

The 21st Century Cures Act was broadly supported in the U.S. Congress for its various provisions, including increased funding for cancer research and the revision of U.S. Food and Drug Administration (FDA) standards for review. The Act authorized $4.8 billion over the next 10 years for cancer research under the Moonshot Initiative, the Precision Medicine Initiative (PMI) and FDA regulatory reform. Appropriation of those funds may prove newly problematic in light of the White House administration’s disclosed budget priorities.


What are the Growth Markets in the Hospital Infection Control Industry?

What are the Growth Markets in the Hospital Infection Control Industry?

The scourge of hospital-acquired-infections (HAIs) will drive market growth for infection control in three segments. Devices that can test for HAIs, equipment to clean and sterilize facilities and devices, and drugs that can treat these threats.


How Big is the Point-of-Care Diagnostics Market? $18 Billion and Climbing

Our new report finds lots of activity and opportunity in near patient testing. The POC diagnostic industry is part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine as emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are transforming the POC landscape. New technologies are making the concept more viable than ever.

  • by Emil Salazar
  • March 8 2017


Current State of the Molecular Transplant Diagnostics Market

Current State of the Molecular Transplant Diagnostics Market

The global market for molecular transplant diagnostics is projected by Kalorama Information to grow in the high single digits each year through 2021. In The World Market for Molecular Diagnostics, 7th Edition, Kalorama identifies bone marrow transplants and high-resolution tissue typing methods as key drivers for the molecular diagnostics market segment. As in other molecular diagnostics areas, established molecular methods for tissue typing face mounting competition from next-generation sequencing (NGS)-based methods.


Big Developments in NGS Market: Assay Kits Appear

Big Developments in NGS Market: Assay Kits Appear

Most sequencing tests performed for clinical applications in the U.S. are laboratory developed tests (LDTs), according to Kalorama Information, meaning that the serviced is performed by test manufacturer and results sent to lab clients. But this is changing, and some of those changes have happened in the last three months. Kalorama Information covers sequencing markets in its report, Next-Generation Sequencing Markets.